Background: Numerous cases of the coronavirus disease 2019 (COVID-19) with
autoimmune and rheumatic manifestations have been reported. Despite the available …

Diagnosis of antiphospholipid syndrome (APS) requires the presence of a clinical criterion
(thrombosis and/or pregnancy morbidity), combined with persistently circulating …

Воспаление и свертывание крови составляют основу защиты организма от
потенциально патогенных механических и биологических воздействий внешней и …

BACKGROUND: Anti-β2GP1 (β2-glycoprotein 1) antibodies are the primary pathogenic
antibody to promote thrombosis in antiphospholipid syndrome (APS), yet the underlying …

Immunopathology may play a significant role in the pathogenesis of Coronavirus-Induced
Disease-19 (COVID-19). Immune-mediated tissue damage could result from development of …

Background Diagnosis of antiphospholipid syndrome (APS) requires persistent presence of
lupus anticoagulant (LAC), anticardiolipin (aCL) IgG/IgM, or anti‐β2 glycoprotein I (aβ2GPI) …

Antiphospholipid antibodies (aPL) comprise a panel of autoantibodies that reflect a potential
prothrombotic risk in several autoimmune conditions, most notably antiphospholipid …

The classification criteria for antiphospholipid syndrome (APS) generate discussion, with a
growing impression that certain patients not fulfilling these criteria might be inadequately …

Objective Non-criteria antiphospholipid antibodies (aPLs) increase the diagnostic value for
antiphospholipid syndrome (APS) and contribute to better recognition of seronegative APS …

The presence of antiphospholipid antibodies was shown to be associated with thrombosis in
coronavirus disease 2019 (COVID-19) patients. Recently, according to reports from several …